#90186
Title: A long term, Multi-Center, Longitudinal Post-Marketing, Observational Registry of Humira (Adalimumab) in children with Active Juvenile Idiopathic Arthritis (JIA)
Eligible subjects: Male and Female 4 to 17 years of age, who are newly prescribed Humira or MTX therapy or have been on the treatments for no more than 6 months prior to baseline, for entrance into the respective treatment arm
Study Location: Round Rock

 

 

For more information or to enroll in a study please call: 1-888-883-3675

---

Print

Share

eMail

Text Size

A

A

A